88 related articles for article (PubMed ID: 20059992)
1. Postprandial apolipoprotein B48 is associated with asymptomatic peripheral arterial disease: a study in patients with type 2 diabetes and controls.
Valdivielso P; Puerta S; Rioja J; Alonso I; Ariza MJ; Sánchez-Chaparro MA; Palacios R; González-Santos P
Clin Chim Acta; 2010 Mar; 411(5-6):433-7. PubMed ID: 20059992
[TBL] [Abstract][Full Text] [Related]
2. Fasting apolipoprotein B48 is a marker for peripheral arterial disease in type 2 diabetes.
Mancera-Romero J; Sánchez-Chaparro MA; Rioja J; Ariza MJ; Olivecrona G; González-Santos P; Valdivielso P
Acta Diabetol; 2013 Jun; 50(3):383-9. PubMed ID: 23053881
[TBL] [Abstract][Full Text] [Related]
3. The role of dietary cholesterol in the regulation of postprandial apolipoprotein B48 levels in diabetes.
Taggart C; Gibney J; Owens D; Collins P; Johnson A; Tomkin GH
Diabet Med; 1997 Dec; 14(12):1051-8. PubMed ID: 9455933
[TBL] [Abstract][Full Text] [Related]
4. Postprandial apolipoprotein B48-and B100-containing lipoproteins in type 2 diabetes: do statins have a specific effect on triglyceride metabolism?
Battula SB; Fitzsimons O; Moreno S; Owens D; Collins P; Johnson A; Tomkin GH
Metabolism; 2000 Aug; 49(8):1049-54. PubMed ID: 10954025
[TBL] [Abstract][Full Text] [Related]
5. Meal testing and postprandial state of type 2 diabetic patients with metabolic syndrome.
Brădescu OM; Georgescu M; Ifrim S; Ioacără S; Ionescu-Tîrgovişte C
Rom J Intern Med; 2005; 43(1-2):97-113. PubMed ID: 16739870
[TBL] [Abstract][Full Text] [Related]
6. Apo E genotype, diabetes, and peripheral arterial disease in older men: the Honolulu Asia-aging study.
Resnick HE; Rodriguez B; Havlik R; Ferrucci L; Foley D; Curb JD; Harris TB
Genet Epidemiol; 2000 Jul; 19(1):52-63. PubMed ID: 10861896
[TBL] [Abstract][Full Text] [Related]
7. Independent association of uric acid levels with peripheral arterial disease in Taiwanese patients with Type 2 diabetes.
Tseng CH
Diabet Med; 2004 Jul; 21(7):724-9. PubMed ID: 15209765
[TBL] [Abstract][Full Text] [Related]
8. Association between C-reactive protein level and peripheral arterial disease among US adults without cardiovascular disease, diabetes, or hypertension.
Shankar A; Li J; Nieto FJ; Klein BE; Klein R
Am Heart J; 2007 Sep; 154(3):495-501. PubMed ID: 17719297
[TBL] [Abstract][Full Text] [Related]
9. Smoking and postprandial triglycerides are associated with vascular disease in patients with type 2 diabetes.
Valdivielso P; Hidalgo A; Rioja J; Aguilar I; Ariza MJ; González-Alegre T; González-Santos P
Atherosclerosis; 2007 Oct; 194(2):391-6. PubMed ID: 16996523
[TBL] [Abstract][Full Text] [Related]
10. Postprandial modulation of serum paraoxonase activity and concentration in diabetic and non-diabetic subjects.
Beer S; Moren X; Ruiz J; James RW
Nutr Metab Cardiovasc Dis; 2006 Oct; 16(7):457-65. PubMed ID: 17015182
[TBL] [Abstract][Full Text] [Related]
11. Influence and interaction of diabetes and lipoprotein (a) serum levels on mortality of patients with peripheral artery disease.
Maca T; Mlekusch W; Doweik L; Budinsky AC; Bischof M; Minar E; Schillinger M
Eur J Clin Invest; 2007 Mar; 37(3):180-6. PubMed ID: 17359485
[TBL] [Abstract][Full Text] [Related]
12. Factors influencing elevated serum apolipoprotein B48 in diabetic and control participants.
Leonard A; Tun TK; Gaffney R; Sharma J; Gibney J; Boran G
Br J Biomed Sci; 2014; 71(4):145-50. PubMed ID: 25562991
[TBL] [Abstract][Full Text] [Related]
13. [Analysis of peripheral arterial obstructive disease related factors among diabetic population aged > or = 50].
Guan H; Liu ZM; Li GW; Guo XH; Xu ZR; Zou DJ; Xing HL; Liu W; Sheng ZY; Tian HM; Zhu DL; Yu DM; Zhuang WT; Chen LL; Weng JP
Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(1):23-7. PubMed ID: 17403307
[TBL] [Abstract][Full Text] [Related]
14. Diabetic nephropathy and risk factors for peripheral artery disease in Chinese with type 2 diabetes mellitus.
Hsieh MC; Tien KJ; Perng DS; Hsiao JY; Chang SJ; Liang HT; Chen HC; Tu ST
Metabolism; 2009 Apr; 58(4):504-9. PubMed ID: 19303971
[TBL] [Abstract][Full Text] [Related]
15. Exploring the value of apoB48 as a marker for atherosclerosis in clinical practice.
Alipour A; Valdivielso P; Elte JW; Janssen HW; Rioja J; van der Meulen N; van Mechelen R; Njo TL; González-Santos P; Rietveld AP; Cabezas MC
Eur J Clin Invest; 2012 Jul; 42(7):702-8. PubMed ID: 22224712
[TBL] [Abstract][Full Text] [Related]
16. Subclinical peripheral arterial disease and incompressible ankle arteries are both long-term prognostic factors in patients undergoing coronary artery bypass grafting.
Aboyans V; Lacroix P; Postil A; Guilloux J; Rollé F; Cornu E; Laskar M
J Am Coll Cardiol; 2005 Sep; 46(5):815-20. PubMed ID: 16139130
[TBL] [Abstract][Full Text] [Related]
17. The relationship of serum lipoprotein lipase mass with fasting serum apolipoprotein B-48 and remnant-like particle triglycerides in type 2 diabetic patients.
Kobayashi J; Nakajima K; Nohara A; Kawashiri M; Yagi K; Inazu A; Koizumi J; Yamagishi M; Mabuchi H
Horm Metab Res; 2007 Aug; 39(8):612-6. PubMed ID: 17712727
[TBL] [Abstract][Full Text] [Related]
18. Association of the -250G/A promoter polymorphism of the hepatic lipase gene with the risk of peripheral arterial disease in type 2 diabetic patients.
Valdivielso P; Ariza MJ; de la Vega-Román C; González-Alegre T; Rioja J; Ulzurrun E; González-Santos P
J Diabetes Complications; 2008; 22(4):273-7. PubMed ID: 18413186
[TBL] [Abstract][Full Text] [Related]
19. Liraglutide Reduces Postprandial Hyperlipidemia by Increasing ApoB48 (Apolipoprotein B48) Catabolism and by Reducing ApoB48 Production in Patients With Type 2 Diabetes Mellitus.
Vergès B; Duvillard L; Pais de Barros JP; Bouillet B; Baillot-Rudoni S; Rouland A; Sberna AL; Petit JM; Degrace P; Demizieux L
Arterioscler Thromb Vasc Biol; 2018 Sep; 38(9):2198-2206. PubMed ID: 30026275
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of risk factors in patients with peripheral arterial disease. A clinical and epidemiological evaluation.
Novo S; Avellone G; Di Garbo V; Abrignani MG; Liquori M; Panno AV; Strano A
Int Angiol; 1992; 11(3):218-29. PubMed ID: 1460357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
